THE DEAL, AT A GLANCE
From the announcementAusperBio
01Who is involvedBacked by RA Capital Management, HanKang Capital, Sherpa Capital, InnoPinnacle FundFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedAusperBio raised $120M Series C, announced 2026-08-27From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersAusperBio's $120M Series C is a sector-positioning signal in a Healthcare / Biotech funding tape that recorded 0 other trailing 30 days rounds totaling $0M.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
AusperBio · Financing Record
Explore source-linked visual explanations for AusperBio. Unsupported claims are withheld while source review continues.
Record 11156 · Recorded date: 2026-08-27
Explore company records →